Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Johnson and Johnson
Medtronic
Harvard Business School
Moodys

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

EMSAM Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Emsam patents expire, and what generic alternatives are available?

Emsam is a drug marketed by Somerset and is included in one NDA.

The generic ingredient in EMSAM is selegiline. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the selegiline profile page.

Drug patent expirations by year for EMSAM
Drug Prices for EMSAM

See drug prices for EMSAM

Recent Litigation for EMSAM

Identify potential future generic entrants

District Court Litigation
Case NameDate
Somerset Pharmaceuticals Inc. v. Dudas2007-05-22

See all EMSAM litigation

Synonyms for EMSAM
(-)-(N)-Methyl-N-((1R)-1-methyl-2-phenylethyl)prop-2-yn-1-amine
(-)-Deprenil
(-)-selegiline
(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine
(R)-(-)-N-Methyl-N-(1-phenyl-2-propyl)-2-propinylamin
(r)-(-)-n,2-dimethyl-n-2-propynylphenethylamine
(R)-(-)-N,alpha-Dimethyl-N-2-propinylphenethylamine
(R)-(-)-Selegiline
14611-51-9
14611-52-0 (hydrochloride)
172964-89-5
2079-54-1 (deprenyl.hydrochloride)
2K1V7GP655
AC1L1BTZ
AC1Q2860
AJ-74093
AKOS000281115
Anipryl
API0009080
Apo-Selegiline
BDBM15579
Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-
Benzeneethanamine, N,alpha-methyl-N-2-propynyl-, (alphaR)-
BPBio1_000687
BRD-K86434416-001-02-7
BRD-K86434416-003-03-1
BRD-K86434416-003-06-4
BSPBio_000623
BSPBio_001589
C07245
Carbex
CHEBI:9086
CHEMBL972
D03731
DB01037
Deprenyl
DTXSID6023575
Eldepryl
Emsam (TN)
FT-0688371
Gen-Selegiline
GTPL6639
HMS1791P11
HMS1989P11
HMS2089D09
HMS3402P11
Jumex
L-Deprenalin
L-Deprenyl
l-E 250
LS-30156
methyl[(2R)-1-phenylpropan-2-yl](prop-2-yn-1-yl)amine
methyl[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-ylamine
MEZLKOACVSPNER-GFCCVEGCSA-N
N-methyl-N-[(1R)-1-methyl-2-phenylethyl]prop-2-yn-1-amine
N-methyl-N-[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-amine
NCGC00024994-01
NCGC00024994-02
NCGC00024994-03
NCGC00024994-04
Novo-Selegiline
Nu-Selegiline
Otrasel
Prestwick0_000552
Prestwick1_000552
Prestwick2_000552
Prestwick3_000552
R(-)-Selegiline solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
SCHEMBL22232
Sd Deprenyl
Selegeline Hcl
Selegene
Selegilina
Selegilina [INN-Spanish]
selegiline
Selegiline (USAN/INN)
Selegiline [INN:BAN]
Selegiline [USAN:INN:BAN]
Selegiline Transdermal System (STS) patch
Selegiline, (R)-Isomer
Selegilinum
Selegilinum [INN-Latin]
Selegyline
selgene
SPBio_002544
STK640578
UNII-2K1V7GP655
UNII-DPF682Q08V component MEZLKOACVSPNER-GFCCVEGCSA-N
UNII-DPF682Q08V component MEZLKOACVSPNER-LBPRGKRZSA-N
US8633208, Deprenyl
Yumex
Zalapar
Zelapar
ZINC19632633

US Patents and Regulatory Information for EMSAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006 RX Yes Yes   Start Trial   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 RX Yes No   Start Trial   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EMSAM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Moodys
AstraZeneca
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.